| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0161-6420(94)31087-6 |
| P8608 | Fatcat ID | release_siht6d5khzfmrf3scuebqbkqhe |
| P698 | PubMed publication ID | 7997324 |
| P2093 | author name string | Kaufman HE | |
| Wilhelmus KR | |||
| Barron BA | |||
| Sugar J | |||
| Jones DB | |||
| Dawson CR | |||
| Hauck WW | |||
| Hyndiuk RA | |||
| Gee L | |||
| Kurinij N | |||
| P2860 | cites work | Acyclovir (Zovirax) in herpetic disciform keratitis | Q33642406 |
| Sequential antibody changes following ulcerative herpetic keratitis | Q33645227 | ||
| Severe herpetic keratitis. I: Prevalence of visual impairment in a clinic population | Q33646489 | ||
| Pathogenesis of corneal oedema associated with herpetic eye disease | Q33648484 | ||
| Changing trends in the indications for penetrating keratoplasty | Q33971601 | ||
| Biology and Molecular Aspects of Herpes Simplex and Varicell-zoster Virus Infections | Q35228586 | ||
| Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway | Q36351920 | ||
| Herpes simplex virus: Molecular biology and the possibility of corneal latency | Q36441661 | ||
| The B-Value: A Tool for Monitoring Data | Q36453425 | ||
| Use of Corticosteroids in Combination with Antimicrobial Drugs in the Treatment of Infectious Corneal Disease | Q37228593 | ||
| Acyclovir ointment plus topical betamethasone or placebo in first episode disciform keratitis | Q37299507 | ||
| Herpes simplex keratitis: role of viral infection versus immune response | Q37729970 | ||
| Diagnosis and management of herpes simplex stromal keratitis | Q39685088 | ||
| Glucorticoid therapy in ocular herpes simplex. I. Limitations | Q40180862 | ||
| Estimation of confidence limits for the cumulative probability of survival in life table analysis | Q41897761 | ||
| Detection of HLA class I and II antigens in rejected human corneal allografts | Q42527658 | ||
| Corticosteroid therapy in central stromal keratitis | Q43977381 | ||
| The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis | Q44172823 | ||
| Historical observations on herpetic keratitis | Q45165555 | ||
| Intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigens in herpes keratitis | Q45235281 | ||
| Design and organization of the herpetic eye disease study (HEDS) | Q46070689 | ||
| Acyclovir versus trifluorothymidine in the therapy of stromal herpes keratitis | Q46675897 | ||
| The current management of herpetic eye disease | Q67575021 | ||
| Corticosteroids: An Unresolved Debate | Q67935464 | ||
| The herpetic Eye Disease Study | Q68928777 | ||
| The relationship of corneal Langerhans cells to herpes simplex antigens during dendritic keratitis | Q69356885 | ||
| Clinical indications for and procedures associated with penetrating keratoplasty, 1983-1988 | Q69521627 | ||
| Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982 | Q69674144 | ||
| Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982 | Q69742268 | ||
| Herpetic keratitis therapy to reduce recurrence | Q69784189 | ||
| Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration | Q71569630 | ||
| Herpes Simplex Treatment with IDU and Corticosteroids | Q76483650 | ||
| TREATMENT OF HERPETIC KERATITIS WITH IDU AND CORTICOSTEROIDS; REPORT OF 105 CASES | Q78511180 | ||
| P433 | issue | 12 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1883-95; discussion 1895-6 | |
| P577 | publication date | 1994-12-01 | |
| P1433 | published in | Ophthalmology | Q7098109 |
| P1476 | title | Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis | |
| P478 | volume | 101 |
| Q39638812 | A cationic TAT peptide inhibits Herpes simplex virus type 1 infection of human corneal epithelial cells |
| Q36591817 | A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo. |
| Q33873874 | A human apolipoprotein E mimetic peptide effectively inhibits HSV-1 TK-positive and TK-negative acute epithelial keratitis in rabbits |
| Q47159636 | A stepping stone in treating dendritic keratitis |
| Q42208798 | A young immunocompetent patient with bilateral immune stromal keratitis due to varicella zoster and herpes simplex |
| Q35303784 | Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers |
| Q36793295 | Are steroids a beneficial adjunctive therapy in the immunosuppressed patient with herpes simplex virus encephalitis? |
| Q35203832 | Bilateral herpetic keratitis presenting with unilateral neurotrophic keratitis in pemphigus foliaceus: a case report |
| Q35080457 | Bilateral herpetic keratoconjunctivitis |
| Q39019254 | Challenges of corneal infections |
| Q28257676 | Clinical correlates of common corneal neovascular diseases: a literature review |
| Q36991715 | Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis. |
| Q36816198 | Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis |
| Q50672500 | Clinical outcomes of keratitis. |
| Q45752035 | Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model |
| Q59121223 | Conjunctival flap covering combined with antiviral and steroid therapy for severe herpes simplex virus necrotizing stromal keratitis |
| Q44165410 | Corneal herpes: what's new? |
| Q38107282 | Corneal oedema and its medical treatment |
| Q90752324 | Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis |
| Q80883371 | Current clinical practice of consultant ophthalmologists in treating herpetic eye disease in the United Kingdom |
| Q36227278 | Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology |
| Q35627056 | Depression and visual functioning in patients with ocular inflammatory disease |
| Q38385726 | Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial |
| Q44820610 | Evaluation of topical 0.03% flurbiprofen drops in the treatment of herpetic stromal keratitis. |
| Q36982412 | Evidence-based medicine audit as a tool for improving emergency ophthalmology. |
| Q36895307 | Evidence-based treatment of herpes simplex virus keratitis: a systematic review. |
| Q30749292 | Fluorescein angiographic monitoring of corneal vascularization in lipid keratopathy |
| Q50436770 | Hearing loss, uveomeningitis, and stroke in a 55‐year‐old man |
| Q37603658 | Herpes simplex keratitis: challenges in diagnosis and clinical management. |
| Q45764879 | Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study |
| Q38858400 | Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. |
| Q46043424 | Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis |
| Q80941945 | Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense |
| Q34621912 | Indecision about corticosteroids for bacterial keratitis: an evidence-based update |
| Q43481758 | Is herpes simplex virus keratitis a different disease in children? |
| Q34512886 | Locally administered ocular corticosteroids: benefits and risks |
| Q39003450 | Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system |
| Q35895208 | Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation |
| Q43187227 | Medical management approach to infectious keratitis |
| Q40355911 | Multimodal Assessment of Corneal Thinning Using Optical Coherence Tomography, Scheimpflug Imaging, Pachymetry, and Slit-Lamp Examination |
| Q83839404 | Ocular herpes simplex |
| Q94569106 | Overview of antiviral medications used in ophthalmology |
| Q35590400 | Pathogenesis and management of herpes simplex virus keratitis |
| Q57476625 | Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation |
| Q73795654 | Polymerase chain reaction in the diagnosis of herpetic keratitis: experience in a developing country |
| Q44670756 | Prescribing trends in infectious keratitis: a survey of New Zealand ophthalmologists |
| Q33380428 | Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. |
| Q37324691 | Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group |
| Q36718011 | Science and strategy for preventing and managing corneal ulceration. |
| Q92461426 | The Binary Classification Of Chronic Diseases |
| Q44922927 | The latest in herpes simplex keratitis therapy |
| Q37160745 | The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole |
| Q35589785 | The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin |
| Q37315329 | The steroids for corneal ulcers trial: study design and baseline characteristics |
| Q33805830 | Treatment of viral diseases of the cornea and external eye. |
| Q98726066 | Update on Herpes simplex keratitis management |
| Q41931288 | Update on the Management of Infectious Keratitis |
| Q30251551 | Use of adjunctive topical corticosteroids in bacterial keratitis |
| Q33682990 | Virus infections of the eye. |
| Q34525914 | Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison |
| Q37201594 | Who (what) pays toll for the development of herpetic stromal keratitis (HSK). |
Search more.